Clinical Trials Browser

Phase 3 × INDUSTRY × brigimadlin × Clear all

NCT06058793 2026-01-09

Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

Phase 3 Completed

Liposarcoma

NCT06370871 2024-07-17

Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma

Phase 3 Withdrawn

Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous